High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study.

BMC Infect Dis · 2005 · PMC1090579 · PMID 15823212

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0670

boldest claim

The sentences

highly significantP < 0.0001actually significant

At the end of IFN-α therapy, 36 patients (47.4%) in 3-MU group and 103 (83.1%) had ETVR, the difference being highly significant (P < 0.0001).

also in 132,142 other papers

borderline significantp = 0.067so close (0.05 < p ≤ 0.1)

The difference was borderline significant by using Kaplan-Meier survival analysis (p = 0.067, figure 2 , left side).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.